Evaluating a Salmonella Typhimurium, Eimeria maxima, and Clostridium perfringens coinfection necrotic enteritis model in broiler chickens: repeatability, dosing, and immune outcomes
Poultry Science · 2023-11 · 102 (11) · 103018
DOI: 10.1016/j.psj.2023.103018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Poultry Science, 2023-11. Verfasst von K Fries-Craft und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Science, Iowa State University, Ames, IA 50011, USA. Hauptthemen laut MEDLINE: Chickens, Poultry Diseases, Clostridium Infections, Coccidiosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Food and Agriculture.
Abstract (Originalsprache)
Coccidiosis and necrotic enteritis negatively impact poultry production, making challenge model repeatability important for evaluating mitigation strategies. Study objectives were: 1) evaluate Salmonella Typhimurium-Eimeria maxima-Clostridium perfringens necrotic enteritis coinfection model repeatability and 2) investigate E. maxima dose and early S. Typhimurium challenge on immune responses. Three trials using Ross 308 chicks assigned to 12 cages/trial (7 chicks/cage) in wire-floor brooders were completed. Trials 1 and 2 determined E. maxima dose for necrotic enteritis challenge in trial 3. Chicks in trials 1 and 2 were inoculated with 0 (control), 5, 15, or 25,000 sporulated E. maxima M6 oocysts on d 14 and jejunal lesion scores evaluated on d 20. In trial 3, chicks were assigned to control or necrotic enteritis challenge (42 chicks/group). Necrotic enteritis challenge chicks were inoculated with 1 × 105 colony forming units (CFU) S. Typhimurium on d 1, 15,000 E. maxima oocysts on d 14, and 1 × 108 CFU C. perfringens on d 19 and 20 with lesion scoring on d 22. Bird and feeder weights were recorded throughout each trial. Peripheral blood mononuclear cells (PBMC) were isolated from 1 chick/cage at baseline (all trials), 4 chicks/dose (trials 1 and 2) or 8 chicks/challenge (trial 3) 24 h post-inoculation (pi) with E. maxima for immunometabolic assays and immune cell profiling. Data were analyzed by mixed procedure (SAS 9.4) with challenge and timepoint fixed effects (P ≤ 0.05, trends 0.05 ≤ P ≤ 0.01). Inoculating chicks with 15,000 E. maxima oocysts increased d 14 to 20 FCR 79 points (trials 1 and 2; P = 0.009) vs. unchallenged chicks and achieved a target lesion score of 2. While C. perfringens challenge reduced trial 3 performance, average lesion scores were
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Animal Science, Iowa State University, Ames, IA 50011, USA.
- Department of Poultry Science, University of Arkansas, Fayetteville, AR 72701, USA.
- Department of Animal Science, Iowa State University, Ames, IA 50011, USA. Electronic address: eabobeck@iastate.edu.
Förderung
- National Institute of Food and Agriculture
Zitieren
APA
Fries-Craft, K., Graham, D., Hargis, B. M., & Bobeck, E. A. (2023). Evaluating a Salmonella Typhimurium, Eimeria maxima, and Clostridium perfringens coinfection necrotic enteritis model in broiler chickens: repeatability, dosing, and immune outcomes. Poultry Science, 102(11), 103018. https://doi.org/10.1016/j.psj.2023.103018
Vancouver
Fries-Craft K, Graham D, Hargis BM, Bobeck EA. Evaluating a Salmonella Typhimurium, Eimeria maxima, and Clostridium perfringens coinfection necrotic enteritis model in broiler chickens: repeatability, dosing, and immune outcomes. Poultry Science. 2023;102(11):103018. doi:10.1016/j.psj.2023.103018
BibTeX
@article{FriesCraft2023,
author = {Fries-Craft, K and Graham, D and Hargis, B M and Bobeck, E A},
title = {Evaluating a Salmonella Typhimurium, Eimeria maxima, and Clostridium perfringens coinfection necrotic enteritis model in broiler chickens: repeatability, dosing, and immune outcomes},
journal = {Poultry Science},
year = {2023},
volume = {102},
number = {11},
pages = {103018},
doi = {10.1016/j.psj.2023.103018}
}
EUVIMED